SME Times is powered by   
Search News
Just in:   • India’s pharmaceutical exports exceed $28 billion up to February  • Bangladesh faces economic strain as Iran war pushes up fuel and food costs  • India’s major ports handled record 915.17 million tonnes of cargo in FY26  • Over 51 lakh LPG cylinders delivered in a day, no dry-out at gas agencies: Centre  • Govt launches programme to train scientists in Governance under Mission Karmayogi 
Last updated: 23 Sep, 2022  

who.thumb.jpg WHO warns against Covid complacency, urges for life-saving action

who.jpg
   Top Stories
» Govt launches programme to train scientists in Governance under Mission Karmayogi
» India's fisheries sector draws Rs 39,272 crore investment since 2015, seafood exports double
» India’s exports to Australia more than double after bilateral trade pact
» India IPO market hits highest Q1 since 2018, raises $2.5 billion
» India’s defence exports surge 62.6 pc to Rs 38,424 crore in FY26, reach over 80 countries
IANS | 23 Sep, 2022
The World Health Organization (WHO) has warned again against complacency in fighting Covid-19, urging for coordinated action and political commitments to save lives and prevent economic and health damage from the ongoing pandemic.

"(Covid-19) pandemic is not over, but the end is in sight ... Being able to see the end does not mean we are at the end," WHO Director-General Tedros Adhanom Ghebreyesus reiterated at a press briefing on Thursday.

He cited as reasons that the pandemic is still inflicting a death toll of 10,000 per week, most of which could be prevented, while large vaccination gaps exist especially in low- and middle-income countries, Xinhua news agency reported.

"That means everyone needs to use, when needed, the simple tools that are available to stay safe: distancing, masks and ventilation. And it means everyone needs access to the medical tools to stay safe: vaccines, tests and treatments," he added.

The WHO chief's remarks came as a working group of ACT-Accelerator Facilitation Council released on Thursday its latest report, warning that the global pandemic is not over and that it's no time for Covid-19 complacency.

Co-founded by WHO and partners, the ACT-Accelerator is a global collaboration to accelerate the development, production, and equitable access to Covid-19 tests, treatments, and vaccines.

The report concludes that many countries are far from meeting global targets on vaccination coverage, testing rates, and access to treatments and PPE. And while progress is being made, the global threat of Covid-19 is far from over, particularly for high-risk groups in lower-income countries.

According to the report, Covid-19 vaccination rates in low-income countries stand only at 19 per cent, compared to almost 75 per cent in high-income countries; and the roll-out of new lifesaving Covid-19 treatments including oral antivirals in low and lower-middle income countries remain limited or non-existent.

The working group recommends that equitable access to Covid-19 countermeasures and preparation for the delivery is critical for countries to integrate the management of the virus into their primary health systems, as part of a longer-term strategy.

It highlights the decline in testing rates and the lack of equitable access to new antiviral treatments for Covid-19, emphasising that diagnostics and therapeutics, as well as associated test-to-treat strategies, are fundamental components of pandemic response, both for Covid-19 and future health threats.
 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹94.25
₹92.55
UK Pound
₹125.95
₹121.95
Euro
₹108.95
₹105.3
Japanese Yen ₹59.4 ₹57.6
As on 02 Apr, 2026
  Daily Poll
What is the biggest war impact on MSMEs?
 Export Disruption
 Raw Material Spike
 Freight Cost Surge
 Payment Delays
 Currency Volatility
 All
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter